Lundbeck
Inha Kim, MD, PhD, currently serves as Vice President and Head of Global Strategy and Communication in Medical Affairs at Lundbeck since May 2023. Prior experience includes roles as Executive Director for Medical Affairs in Northern Europe focusing on Rare Diseases at PTC Therapeutics, and leadership positions in Medical Affairs at AstraZeneca, Olympus Surgical Technologies Europe, Merz Pharmaceuticals, and sanofi-aventis, covering therapeutic areas such as neurology, respiratory diseases, and cardiovascular health. Inha Kim's extensive background also includes a period as a neurologist at Uniklinik Charite Berlin, specializing in various neuropsychiatric conditions. Academic credentials include an MD and PhD in Medicine from Freie Universität Berlin.
This person is not in any teams
This person is not in any offices
Lundbeck
43 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.